Structural mapping of oligomeric intermediates in an amyloid assembly pathway.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31552823.
- Also identified by DOI 10.7554/eLife.46574 and PMC identifier 6783270.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Transient oligomers are commonly formed in the early stages of amyloid assembly. Determining the structure(s) of these species and defining their role(s) in assembly is key to devising new routes to control disease. Here, using a combination of chemical kinetics, NMR spectroscopy and other biophysical methods, we identify and structurally characterize the oligomers required for amyloid assembly of the protein ΔN6, a truncation variant of human β<sub>2</sub>-microglobulin (β<sub>2</sub>m) found in amyloid deposits in the joints of patients with dialysis-related amyloidosis. The results reveal an assembly pathway which is initiated by the formation of head-to-head non-toxic dimers and hexamers <i>en route</i> to amyloid fibrils. Comparison with inhibitory dimers shows that precise subunit organization determines amyloid assembly, while dynamics in the C-terminal strand hint to the initiation of cross-β structure formation. The results provide a detailed structural view of early amyloid assembly involving structured species that are not cytotoxic.
Medical subject headings
- Amyloid
- Macromolecular Substances
- Protein Multimerization
- beta 2-Microglobulin